Leonardo Velazco-Cruz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leonardo Velazco-Cruz has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Jeffrey R. Millman
Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, USA
2 shared publications - Punn Augsornworawat
Department of Immunology Faculty of Medicine Siriraj Hospital Mahidol University, Bangkok, Thailand
2 shared publications - Fumihiko Urano
Department of Medicine, Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA
1 shared publication Kristina G. Maxwell
Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO 63110, USA
1 shared publication- Kristina G. Maxwell
Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, USA
1 shared publication - Michelle H. Kim
School of Medicine Duke University Durham North Carolina USA
1 shared publication
Latest Publications
- Open Access
- 1 August 2020
- Published by Elsevier in Cell Reports
- Vol. 32 (8) , 108067
Single-Cell Transcriptome Profiling Reveals β Cell Maturation in Stem Cell-Derived Islets after Transplantation
- 1 August 2020
- Published by Elsevier in Cell Reports
- Vol. 32 (8) , 108067
Open AccessSingle-Cell Transcriptome Profiling Reveals β Cell Maturation in Stem Cell-Derived Islets after Transplantation
- 22 April 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (540)
Gene-edited human stem cell–derived β cells from a patient with monogenic diabetes reverse preexisting diabetes in mice
Patient stem cell–derived β cells corrected for a diabetes-causing variant in WFS1 restore glucose homeostasis when transplanted into diabetic mice.
- 22 April 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (540)
Gene-edited human stem cell–derived β cells from a patient with monogenic diabetes reverse preexisting diabetes in mice
Patient stem cell–derived β cells corrected for a diabetes-causing variant in WFS1 restore glucose homeostasis when transplanted into diabetic mice.